2021 RESEARCH
- Archives -UMass MIND awarded drama therapy grant by National Endowment of the Arts
Xiaoduo Fan, MD, MPH, is principal investigator of a collaboration between UMass MIND and Lesley University to investigate virtual drama therapy for individuals recovering from serious mental illness, who often do not respond to conventional treatment methods.
Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trial
Oguz Cataltepe, MD, describes the innovative neurosurgical procedure used to treat patients in the new clinical trial for a gene therapy targeting infantile Tay-Sachs and Sandhoff diseases.
Two UMass Medical School research teams chosen to compete in STAT News competition
Two research teams from UMass Medical School have been selected by STAT News to compete among 64 contestants in the 2021 STAT Madness competition. Voting begins March 1.
Research by Mark Johnson provides insights into origins of idiopathic normal pressure hydrocephalus
A UMass Medical School neurosurgery research team has unlocked a genetic component underlying a mysterious brain disorder known as idiopathic normal pressure hydrocephalus, a condition whose symptoms are often mistakenly attributed to other diseases or age.
UMMS soars in NIH funding, Blue Ridge Institute rankings
In 2020, UMass Medical School advanced to 21st in National Institutes of Health funding among the 140 medical schools, public and private, that receive NIH funding, according to the Blue Ridge Institute for Biomedical Research.
Medical student Kendall Burdick examining geographic, racial disparities in access to pediatric trauma care
Kendall Burdick, SOM ’23, is studying geographic and racial disparities in access to pediatric trauma care with a Medical Student Research Grant from the Emergency Medicine Foundation and the Society for Academic Emergency Medicine.
Preventative shot for Lyme disease, developed at UMass Medical School, enters clinical trial
Lyme PrEP, a seasonal shot to prevent Lyme disease developed by MassBiologics at UMass Medical School, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment.
UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research
Five UMass Medical School scientists from the UMass Diabetes Center of Excellence are part of the JDRF Center of Excellence in New England that launched Feb. 23. The goal of the is to create a cell replacement therapy that could treat and potentially cure type 1 diabetes.
UMass Medical School taking part in CDC project on COVID-19 vaccine in health care staff
UMass Medical School is participating in a public health project funded by the Centers for Disease Control and Prevention that aims to measure the effectiveness of COVID-19 vaccines in individuals who work or train in a hospital care setting.
FDA approves Investigational New Drug Application for DNA/prime-protein boost vaccine to prevent HIV infections
Worcester HIV Vaccine has received clearance from the FDA for its Investigational New Drug application for a novel polyvalent DNA/prime-protein boost vaccine to prevent HIV.